German CDMO Strength Labtec is a long-standing German contract development and manufacturing organization with almost 30 years of experience in transdermal systems and oral films, positioned to attract pharma companies seeking reliable, compliant end-to-end drug delivery development and manufacturing.

Acquisition Upside Recent corporate actions include Adhexpharma's acquisition of Labtec and a strategic partnership with tesa Labtec, indicating growth, expanded geographic footprint in Germany, and potential cross-sell opportunities within a larger corporate platform.

Full-Service Offering Labtec provides end-to-end capabilities from portfolio screening to packaging, enabling pharma customers to consolidate vendors; emphasize opportunities with companies looking to simplify supply chains for transdermal, buccal, and oral film technologies.

Regulatory & Quality Lean With ISO 14001 and a track record of high quality and regulatory compliance, Labtec can target firms seeking robust QA/QA-assisted scale-up for compliant manufacturing, potentially reducing audits and contractor overhead.

Mid-Market Focus Current revenue range suggests mid-market client base; tailor outreach to midsize pharma and specialty drug companies seeking innovative delivery systems and contract manufacturing capacity without engaging Large Enterprise budgets.